2008 TEPR Awards Honorees Announced ( Outstanding Health I...)

2008 TEPR Awards Honorees Announced

Date:5/20/2008

Outstanding Health IT Solutions Recognized

BOSTON, May 20 /PRNewswire/ -- Medical Records Institute (MRI) announced today the 2008 TEPR Awards honorees during the Opening Session of the 24th Annual TEPR (Towards the Electronic Patient Record) Conference in Ft. Lauderdale, Florida.

TEPR Awards annually recognize outstanding health IT and electronic medical record innovations and solutions. The 2008 TEPR Awards honorees are:

Personal Health Record Systems

Recognizing superior providers of PHR systems based on criteria such as data, data integrity, security, and consumer control.

1st Honors: CapMed

2nd Honors (tie): Doctations and Passport MD

Hot Products

Recognizing the most innovative IT products bringing the most positive benefits to healthcare.

1st Honors: MediNotes' Clinician Supply Chain Manager

2nd Honors: XLEMR's SOX - The Physician's Quickbooks Accounting Robot

3rd Honors: CapMed's icePHR Mobile

EMR Systems Best Meeting Medicolegal Requirements

A new TEPR Awards category recognizing EMRs best meeting medicolegal requirements based on criteria such as identity/authentication, documentation version management, signature events, data integrity, and document event auditing functions.

1st Honors (tie): Doctations and eMedicalFiles

Prior to TEPR, industry experts, who served as independent judges, reviewed Award applications, assessed them and selected finalists in each category. Then at TEPR, on Sunday, May 18, finalists presented their solutions before judges and TEPR registrants. Judges determined Honors in each category, and the honorees were officially recognized at the TEPR Opening Session.

About Medical Records Institute, Inc.

MRI's mission is to promote and enhance the journey towards electronic medical records, e-health, and related information technologies. MRI serves as an international forum for sh
'/>"/>

SOURCE Medical Records Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. BWF awards $11.2 million to support physician-scientists
2. Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year
3. Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million
4. National Business Group on Health Awards Gold to Blue Cross and Blue Shield of Minnesota for Promoting a Healthy Workplace
5. Keck Futures Initiative awards $1M for 15 research projects
6. Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala
7. NIH awards LIAI major grant to test safety of new smallpox treatment
8. Mangos Captures 11 HMR Awards
9. The American Psychiatric Associations Awards for Young Scientists Encourage Research Expertise in China
10. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
11. SRG Scoops Two Recruiter Awards for Excellence

Post Your Comments:

(Date:12/5/2013)... Garden City, NY (PRWEB) December 05, 2013 ... and President of The KeLaHa Projects Foundation, as ... with this prestigious distinction. As the largest, most-recognized ... virtually every industry and profession, the National Association ... nearly 500,000 members and over 400 Local Chapters ...

(Date:12/5/2013)... 05, 2013 Who: Dr. Rodney Lemery, ... What: Webinar: " Evaluating and Investigating Drug Safety Signals ... BioPharm's Dr. Rodney Lemery, vice president of safety ... databases available to use during the evaluation and investigation ... the use of free and paid longitudinal healthcare databases ...

(Date:12/5/2013)... Dalvia Wellness Labs, a US-based company known for offering ... of its latest product – Dalvia L-Arginine Amino Acid ... company, this product has been specifically formulated to help people ... of the specific components of L-arginine – an amino acid ... vital body organs. , Studies have shown that L-arginine is ...

(Date:12/4/2013)... 2013 A new guideline released Thursday ... that most people with compromised immune systems are especially ... and other vaccinations. The guideline, entitled “Clinical Practice ... authored by Lorry G. Rubin, MD, director of the ... New York in New Hyde Park, NY, and professor ...

(Date:12/4/2013)... 2, 2013 Medical researchers point to developmental ... melatonin, as an explanation for why children get ... new study suggests that social ties, including relationships ... responsible for changing sleep patterns among adolescents. , ... important than biological development as predictors of teen ...

Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Keoma L. Hamer, Founder and President of The KeLaHa Projects Foundation, as VIP Woman of the Year 2 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 2 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 3 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 4 Health News:Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched 2 Health News:Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched 3 Health News:Cohen Pediatric Infectious Disease Chief Authors New Vaccination Guideline for Immunocompromised Patients 2 Health News:Social ties more important than biology when it comes to teen sleep problems 2 Health News:Social ties more important than biology when it comes to teen sleep problems 3

[0] National Association of Professional Women Announces Keoma L. Hamer, Founder and President of The KeLaHa Projects Foundation, as VIP Woman of the Year [0] BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases [0] Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched [0] Cohen Pediatric Infectious Disease Chief Authors New Vaccination Guideline for Immunocompromised Patients [0] Social ties more important than biology when it comes to teen sleep problems

... BASEL, Switzerland, Oct. 29 Roche (SWX: ROG.VX; RO.S),a ... it has extended its offer to acquire all of ... VMSI ),to 5:00 p.m., New York City time ... scheduled to expire at 5:00 p.m., New York City ...

... AIDS virus entered the United States via Haiti, probably arriving ... believed, according to new research. , After the virus, ... , "Our results show that the strain of virus ... around 1969. That is earlier than a lot of people ...

... or shorten the illness , MONDAY, Oct. 29 (HealthDay News) ... prevent pneumonia in elderly nursing home residents, a new study ... 617 people 65 and older in 33 nursing homes in ... blood zinc concentrations were about 50 percent less likely to ...

... produced responses in 40% of patients with Philadelphia, chromosome-positive chronic myeloid ... ... and availability in US means Novartis can offer physicians and ... EAST HANOVER, N.J., Oct. 29 Tasigna(R),(nilotinib) capsules have been approved in ...

... of Hepatitis C Treatment to Ongoing Oncology Program ... Ono Pharmaceutical,Co., Ltd. and Medarex, Inc. (Nasdaq: ... new drug application (IND) filed with the U.S. ... code of Ono,Pharmaceutical Co., Ltd.), a fully human ...

... Science,Corporation (Nasdaq: CSCX ), a global leader ... that it will present at the,18th Annual CIBC ... The,Company,s presentation is scheduled for Monday, November 5, ... and chief executive officer, will,review the Company,s business ...

Roche Extends Tender Offer for Ventana HIV's path out of Africa: Haiti, the US then the world Zinc Helps Elderly Ward Off Pneumonia Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody Cardiac Science to Present at the 18th Annual CIBC World Markets Healthcare Conference

(Date:12/5/2013)... 2013 Catabasis Pharmaceuticals, Inc. , today ... trial investigating the safety and efficacy of CAT-2003 ... triglyceride levels of 500 mg/dL or greater. CAT-2003 ... 3 fatty acid, eicosapentaenoic acid (EPA), employing Catabasis, ... second Phase 2 trial of CAT-2003, patients with ...

(Date:12/5/2013)... 5, 2013 Eli Lilly and Company (NYSE: ... from three studies of edivoxetine did not meet ... depression after eight weeks of treatment. When added ... did not separate from placebo on the Montgomery-Asberg ... placebo-controlled Phase III studies (LNBM, LNBQ and LNBR). ...

(Date:12/5/2013)... Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... Annual Healthcare Conference to be held at the ... , December 10-11, 2013. Michael ... the Company and its lead drug candidate, Quizartinib, at ...

Breaking Medicine Technology:Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia 2 Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia 3 Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder 2 Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder 3 Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference 2

[0] Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia [0] Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder [0] Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference

... SAN CARLOS, Calif., June 23, 2011 PharmacoFore, ... abuse-resistant prescription drugs, today announced positive results from ... its hydromorphone (HM) Bio-Activated Molecular Delivery™ (Bio-MD™) product ... will present at the 2011 BIO Business Forum ...

... Today,s U.S. Supreme Court decision in ... safety, giving generic drug companies legal immunity when they ignore ... This decision eliminates any incentive for generic manufacturers to ensure ... drugs, potential dangers. This decision also means that ...

Cached Medicine Technology:PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 2 PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 3 PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 4 Generic Drug Decision Disastrous to Patient Safety 2

PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was Generic Drug Decision Disastrous to Patient Safety

ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...

... ophthalmic solution is a prescription eye ... you to use after your cataract ... and may cause them to become ... of inflammation include redness and swelling. ...

Store and manage many ECG data from ECG-9020, ECG-9130 or ECG-9320 on the PC. You can search, view, compare, print, and edit analysis results of ECG, and send it to other physicians by e- mail....

Medicine Products:

ALPHAGAN® P 15 mL ALPHAGAN® P 5 mL ACULAR® 10 mL ECG Viewer